ABSTRACT… Background: This study was carried out to determine the role of total serum alkaline Phosphatase in bone metastasis among patients of breast cancer. Setting; Department of Surgery, Nishtar Medical University, Multan in collaboration with breast clinic MINAR. Study Duration; January 2016 to June 2017 Subjects and methods; It was a retrospective study carried out at breast clinic MINAR, Multan. The medical record of the female patients having breast cancer aged 25 to 70 years (who presented from January 2016 to June 2017) was scrutinized. All the registered patients during above mentioned period having breast carcinoma with metastatic bone disease, as depicted on bone scan, were taken as index cases. All the cases underwent total serum alkaline Phosphatase estimation. We collected 86 cases for this research study. Primary bone tumours, lymphomas, sarcomas and bone metastasis due to other primary visceral malignancies were excluded. All the required data were entered and analyzed using computer program SPSS version 20.0. Results; The mean age of the breast cancer patients was 46.51 ± 11.11 years (ranging from 25 -70 years). Eighty four (97.7%) were married. All the patients presented with lump breast. Only 3 (3.5%) of the cases gave family history of breast cancer and history of contraceptive pills was positive in 4 (3.7%) of the cases. History of breast feeding was positive in 63 (73.3%) of the cases. Mean age at menarche was 13.21± 0.896 years in our study cases. Mean age at menopause in our study was 46.86 ± 5.66 years. Total serum alkaline Phosphatase was raised in 27 (31.4%) cases. Only 6 (6.9%) of the cases showed its level more than 500 IU/L. Conclusion; Our study results don't favor total serum alkaline Phosphatase estimation as biological marker of bone metastasis among breast cancer patients. Bone scan is more reliable and hence be employed for detection of bone metastasis. Further studies on bone ALP and total ALP estimation are required to generate further evidence on this subject.
INTRODUCTION
Breast cancer is the commonest cancer among females globally as well as nationally. It is the leading cause of cancer deaths in women. 1, 2 Breast cancer accounts for 22% of all female cancers worldwide and approximately 42% cases occur in the developing countries. 6 In USA, it has been found that 60% of patients have benign breast disease and 10% have malignancy. 7 In Pakistan, a study carried out in 2001 reported a very low incidence of breast cancer (6%) 8 , while another study in 2003 reported a frequency of 24.2%. A study from Karachi, at Jinnah Postgraduate Medical Centre, in 2005 showed that 30% of malignancies among females occur in the breast. 9 There is also geographic variation, with the standardized age incidence rate being lower in developing than industrialized countries. 10 The new millenniums still find breast cancer as a leading cause of cancer related death among females. It is expected that the number of new cases may rise to 15 million by 2025, with 60% of the cases occurring in developing countries. 9 The disease occurs commonly among females but may also occur very less frequently in males. 3, 4 It is seen that if 100 female patients present with breast complaints, then among them 30% may have no breast lesion, 40% may have fibrocystic changes, 7% may have benign tumor and 10% may have carcinoma. 5 Breast carcinoma spreads either regionally (to regional lymph nodes) or systemically. It most frequently metastasizes to bones in addition to lung, liver and brain. 11, 12, 13 For staging and for therapeutic options for breast carcinoma it is necessary to detect the bone metastasis in these cases. Various tests are used to detect bone metastasis and simplest of all is total serum alkaline Phosphatase estimation. It is also raised in obstructive hepato-billiary disease, bone fractures, pregnancy, in growing children and even in old age. Some of these conditions are ruled out on history and some by other parallel tests like estimation of gama GT, bone Skiagrams and liver ultrasonography. The gold standard test for bone metastatis detection is bone scan, however total serum alkaline Phosphatase is still being used as basic test for prediction of bone metastasis in some countries. If it is raised two times above normal or more than this, it is taken as abnormal and points towards some pathology. In patients of carcinoma breast its raised level points to some bony involvement and 14 levels above 500 IU/L raises the possibility of bone mets 15 , however may remain even normal in some cases of breast cancer with metastatic bone disease. 16 The same trend was observed at our breast clinic during the evaluation of breast cancer patients. So the present study was carried out to detect the significance of total Serum Alkaline Phosphatase estimation in prediction for bone metastasis in patients of breast carcinoma at a tertiary care hospital.
SUBJECTS AND METHODS
It was a retrospective study carried out at breast clinic MINAR, Multan. The medical record of the female patients having breast cancer aged 25 to 70 years (who presented from January 2016 to June 2017) was scrutinized. All the registered patients during above mentioned period having breast carcinoma with metastatic bone disease, as depicted on bone scan were taken as index cases. All the patients also underwent total serum alkaline Phosphatase estimation. We collected 86 cases for this research study. Primary bone tumours, lymphomas, sarcomas and bone metastasis due to other primary visceral malignancies were excluded. All the required data was entered and analyzed using computer program SPSS version 20.0.
RESULTS
We examined medical record of 86 index cases. The mean age of the breast cancer patients was 46.51 ± 11.11 years (ranging from 25 -70 years). Eighty four (97.7%) were married. All the patients presented with lump breast. Only 3 (3.5%) of the cases gave family history of breast cancer and history of contraceptive pills was positive in 4 (3.7%) of the cases. History of breast feeding was positive in 63 (73.3%) of the cases. Mean age at menarche was 13.21± 0.896 years in our study cases. Mean age at menopause in our study was 46.86 ± 5.66 years. Total serum alkaline Phosphatase was raised in 27 (31.4%) cases. Only 6 (6.9%) of the cases showed its level more than 500 IU/L. respectively. These differences may be again due to cultural variations. Moreover, our study patients were house-wives and jobless and from poor socioeconomic status, so they were unable to afford formula milks.
DISCUSSION
Mean age at menarche was 13.21± 0.896 years in our study cases while Memon et al 17 from Karachi reported 12.96±1.60 years mean age at menarche. The same findings have been reported by Nazir et al. 19 These both findings are in consonance with our study results.
Mean age at menopause in our study was 46.86 ± 5.66 years which is in compliance with other studies conducted by Memon et al 17 from Karachi who reported 46.35 ± 6.65 years mean age of the ladies with breast cancer.
Alkaline Phosphatases and its various isoenzymes are phosphatidylinositol anchored cell membrane proteins. Raised serum ALP has various clinical implications. It is raised in various conditions like intra and extra hepatic billiary obstruction, infiltrative liver disease, bone mets and cancers. ALP estimation is an inexpensive and is used in various developing countries as a potential biological marker. In some studies on breast cancer its parallel rise with advancing disease has been noted. 23 In our study, total serum alkaline phosphatase level was raised in 31.4% of patients while its level more than 500 IU/L was noted in 6.9 %. , it may be due to the reason that the patients in our study may not have so advanced disease. Total ALP may be useful diagnostic tool in monitoring the activity of the disease where sophisticated tools are not readily available moreover its estimation is simple and cost-effective but its significance in detection of bone mets remains controversial.
With the recent advent of more specific immuneassays like bone ALP estimation has gained clinical interest and several studies have indicated that in certain situations bone ALP might provide better index of bone formation than measurement of total ALP. They also reported that bone ALP was more frequently raised in bone metastatic disease of prostatic cancer patients compared to the patients of breast cancer or lung cancer with bone mets. So, bone alkaline Phosphatase estimation might have provided better picture on this subject than total ALP but this test was not available in our setting so total serum alkaline Phosphatase was estimated in our study cases.
CONCLUSION
Our study results don't favor total serum alkaline 
